accountseventh paragraph; adds closing share prices.) May 13 (Bloomberg) -- Teva Pharmaceutical Industries Ltd., Mylan Inc. and Anchen Pharmaceuticals Inc. won a judge���s ruling over their planned generic version of the muscle-relaxant Amrix. Cephalon Inc. and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Teva, Mylan Anchen Win Patent Ruling Over Amrix Infringement
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account